MOVE News

Movano Health Granted Listing Extension by Nasdaq

MOVE

(NASDAQ:MOVE) PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that, by letter received on August 27, 2025, the Nasdaq Hearings Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq") has determined to grant the Company's request to...

August 28, 2025Listing
Read more →

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

MOVE

PLEASANTON, Calif., Aug. 22, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its...

CORRECTION: Movano Announced Its Nasdaq Notification Of Deficiency On May, 23

MOVE

June 6, 2025
Read more →

Movano Receives Notice of Deficiency From Nasdaq Regarding Delayed Filing Of Quarterly Report On Form 10-Q

MOVE

May 23, 2025
Read more →

Trading Halt: Halt status updated at 4:55:00 PM ET: Quotation Resumption: News and Resumption Times

MOVE

May 16, 2025
Read more →

Movano Health Explores Strategic Alternatives, Including Potential Sale Or Merger

MOVE

May 16, 2025
Read more →

Trading Halt: Halted at 4:25:00 p.m. ET - Trading Halt: Halt News Pending

MOVE

May 16, 2025
Read more →

Movano Q3 EPS $(1.06) Up From $(2.65) YoY, Sales $50.00K

MOVE

November 14, 2024
Read more →

Movano Health Continues To Work With Securities Regulators, Legal Advisors And Other Partners To Protect Interests Of Shareholders

MOVE

November 4, 2024
Read more →

Movano Health Submits A Complete Response Package To The FDA As Part Of The Final Phase Of The Company's 510(k) Application Review Of The EvieMED Ring

MOVE

November 4, 2024
Read more →

Movano Health To Investigate Possible Stock Manipulation Following Reverse Split

MOVE

October 31, 2024
Read more →